Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-07-03
2007-07-03
Aulakh, Charanjit S. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S075000
Reexamination Certificate
active
10344420
ABSTRACT:
New aporphine derivatives are disclosed which have formula (I) and the physiologically acceptable salts thereof. Said derivatives may be used for the treatment of Parkinson's disease, hemicrania, restless legs syndrome (RLS), sexual dysfunction in men and women, hyperprolactemia and psychotic disorders, and/or evaluation of Parkinson's disease. Processes for the preparation of such derivatives are also disclosed.
REFERENCES:
patent: 4080456 (1978-03-01), Seidelmann et al.
patent: 4279914 (1981-07-01), Maasbol et al.
patent: 2005/0143408 (2005-06-01), Wikstrom et al.
patent: 0040074 (1981-11-01), None
patent: 2373530 (1978-07-01), None
patent: WO 97/06786 (1997-02-01), None
patent: WO 98/31368 (1998-07-01), None
patent: WO 99/62502 (1999-12-01), None
patent: 0003698 (2000-01-01), None
patent: 0069416 (2000-11-01), None
patent: WO 02/14279 (2002-02-01), None
STN International, File CAPLUS CAPLUS accession No. 1981:47565, document No. 94:47565 J.F. Green et al.: “Aporphines. XXVI: GLC and mass spectrometric properties of trifluoroacetyl derivatives of N-methyl-, N-propyl-, and noraporphines”.
STN International, File CAPLUS CAPLUS accession No. 1978:70, document No. 88:70 D. Michael Baaske et al.: “Gas chromatographic determination of apomorphine in plasma”.
J. F. Green, et al., “Aporphines XXVI: GLC and Mass Spectrometric Properties of Trifluoroacetyl Derivatives of N-Methyl-, N-Propyl-, and Noraporphines”, Journal of Pharmaceutical Sciences, vol. 69, No. 8, Aug. 1980, pp. 936-942.
D. Michael Baaske, et al., “Gas Chromatographic Determination of Apomorphine in Plasma”, Journal of Chromatography, vol. 140, 1977, pp. 57-64.
Andrén Per Erik
Cremers Thomas
Dijkstra Durk
Jurva Ulrik
Marchais Sandrine
Aulakh Charanjit S.
Axon Biochemicals B.V.
LandOfFree
Aporphine esters and their use in therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aporphine esters and their use in therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aporphine esters and their use in therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3780457